AstraZeneca's breast cancer drug fails in late-stage trial
AstraZeneca's breast cancer drug fails in late-stage trial KSL
AstraZeneca's breast cancer drug fails in late-stage trial KSL
Update on SERENA-4 Phase III trial of Etcamah in combination with palbociclib in upfront 1st-line advanced ER-positive breast cancer AstraZeneca
ASTRO updates guideline on radiation therapy for pancreatic cancer The Cancer Letter
Zipalertinib + chemo meets primary endpoint in phase III REZILIENT3 trial in first-line EGFR exon 20 insertion mutation NSCLC The Cancer Letter
Онколог рассказал о трех привычках, которые чаще всего приводят к раку health.mail.ru
Phoebe Ongadi: Shaping an Africa-Led Future for Cancer Research Oncodaily
100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond oncodaily.com
Shilpa Gupta: Riding to Advance Cancer Research at Cleveland Clinic oncodaily.com
Daniel Flora: Riding 50 Miles for Cancer Research in Cincinnati oncodaily.com
Building Better CAR T-Cells For Cancer Treatment Mirage News
Building Better CAR T-Cells for Cancer Treatment UNC Health
The Conversations That Shape Cancer Care: Lessons Learned From Communicating With Patients ASCO Connection
A research team at Huntsman Cancer Institute at the University of Utah (the U) has found that obesity prevents a biological process that kills cancerous cells, revealing a possible reason obesity is a risk factor for breast cancer.